Education 2000 PhD, graduated from University of Copenhagen, Faculty of Health Science. Thesis: Cotrimoxazole and Fansidar in the treatment of acute uncomplicated falciparum malaria: Efficacy, safety and molecular characterisation of resistance.
1996 Diploma in Tropical Medicine and International Health, University of Copenhagen,
MS (Medical Biochemistry.) graduatedfrom Faculty of medicine, University of Khartoum, Sudan.
Record of experience 05-08 2006- Researcher at Rigshospitalet, Finsencentret / Epidemiklinikken, afsnit 7641. Writing of the proposed project “Repatriation and Resistance: Risks for Returning Internal Displaced People to South Sudan, using Malaria as an Indicator” submitted to RUF/DANIDA 19th of June 2006. Preparation of clinical interaction protocol (Concerning artemisinin combination therapy and anti retroviral treatments) and development of immunoassays for the analysing disethyl amodiaquine, mefloquine and lumefantrine in biological fluids. 2004-04.2006
Adjunct at Centre of Medical Parasitology (CMP) and Institute of
International Health/CISU (University of Copenhagen). Development of monoclonal antibody-based immunoassays for the analysis of the antimalarial drugs chloroquine and amodiaquine (project no. 91197 funded by RUF and Department of international Health, University of Copenhagen).
2002-2003 Research adjuncts at CMP. Studying malaria drug resistance in Sudan & Tanzania,
assist in development of immuno-blot assays (PCR-based ELISA and Dot-blot) for detecting dihydrofolate reductase, dihydropteroate synthase, chloroquine resistant transporter and P. falciparum multi-drug resistant
Reviewer for Journal of Post graduate medicine.
2006 Supervisor for the visiting Sudanese PhD student Maha El-HAdi (Project title:
Determination of molecular markers for artemisinin resistance in central and east
Reviewer for American Journal of Tropical Medicine and Hygiene.
Members in Danish Society for Tropical Medicine & Hygiene.
2005- Member in Cluster of International Health, University of Copenhagen. 2005
Supervisor for the visiting Sudanese PhD student Ishragha El-Tayeb (Project title: Determination of molecular markers of chloroquine and Fansidar resistance in eastern Sudan 01.08-03.11. 2005).ern Sudan 01.02-01.05.2006).
Analysis of chloroquine levels in pregnant women enrolled in an intermittent
presumptive treatment in Burkina Faso (October 2005-March 2006).). 2003 Fund from IB Bygbjerg, Dept. International. Health, University of Copenhagen. 2004-2006 Post-doc from RUF (project no. 91179, date 01-04.2004-28.02.2006). Brief description of Research area in question: Researcher and collaborator in a number of studies on molecular aspects of antimalarial drug
resistance and analysis of antimalarial drugs and epidemiology. Supervisor to Sudanese The research as well involved collaboration with research institutions in Tanzania , Burkina Faso and Sudan. Being the principal investigator in 2 projects of developing antibodies to five antimalarial drugs, the applicant has the knowledge, the laboratory experince and talent to do the proposed project. The applicant will be working under supervision of Dr Claus koch, who is a pioneer in the field of developing monoclonal antidodies and immuno-assays to different antigens.
Researcher in the Regional Project (RAF/6/017) of the International Atomic Energy Agency (IAEA) for "The Use of Isotopes in Detection of Drug Resistant Malaria & Tuberculosis" Awards: 1992-1995 M.Sc. Scholarship from Danish International development Agency (DANIDA). 1995 Diploma of Tropical Medicine & International Health Scholarship from DANIDA (Oct 95-Dec). 1997-2000 Ph.D. Scholarship from the Danish International Development Agency (DANIDA Publications Total number of published articles in international, refereed scientific journals: 13 Recently published articles in international refereed scientific journals: 1-Ibrahim AM, Kheir MM, Osman ME, Khalil IF, Alifrangis M, Elmardi KA, Malik EM, Adam I. Efficacies of artesunate plus either sulfadoxine-pyrimethamine or amodiaquine, for the treatment of uncomplicated Plasmodium falciparum infection in eastern Sudan. Ann Trop Med Parasitol. 2007 101: 15-21 2-Adam I, Magzoub M, Osman ME, Khalil IF, Alifrangis M, Elmardi KA: A fixed dose 24—hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for treatment of uncomplicated malaria in eastern Sudan. Ann. Clin Microbiol Antimicrob.2006 August 26; 5(1):18 3- Alifrangis M, Dalgaard M, Lusingu JP, Vestegaard LS, Staalsoe T, Jensen ATR, Enevold A, Rønn NM, Khalil IF, Lemnge MM, Theander TG and Bygbjerg IC. Occurance of the Plasmodium falciparum chloroquine resistant transporte (pfcrt) South-East Asian/South American SVMNT haplotype in parasites from Tanzania. JID 2006. Jun 15; 193 (12):1738-41.
4- Elbasit EM, Elbashir, MI, Alifangis M, Khalil IF. The efficacy of sulfadoxine-pyrimethamine alone and in combination with chloroquine, for malaria treatment in Eastern Sudan: The
interrelation between resistance , age and gametocytogenesis. Trop Med Int Health. 2006 May: 11 (5):604-12. 5- Dittrich S, Alifrangis M, Vanisaveth V, Phetsouvanh, Khalil IF, Jelinek T. Falciparum malaria in the north of Laos: the occurrence and implications of the P. falciparum chloroquine resistance transporter (pfcrt) gene haplotype SVMNT. Trop Med Int Health. 2005 Dec; 10 (12): 1267-70. 6- Khalil IF, Alifrangis M, Hoegberg LCG, Recke C, Bygbjerg IC, Koch C & Rønn AM. Development of a monoclonal antibody based competitive -ELISA for measuring chloroquine concentration in biological Fluids. Acta Tropica 2005; Supplement 95S, ISSN 0001-706X.pp: S244. 7- KhalilL IF, Rønn AM, Alifrangis M, Abdelgabar, Jelinek T , Satti GMH and Bygbjerg IC. Response of P. falciparum to cotrimoxazole therapy: Relation to plasma drug concentrations, dihydrofolate reductase and dihydropteroate synthase genotypes. American Journal of Tropical Medicine and hygiene. 2005 Jul; 73 (1): 174-7. 8- Alifrangis M, Enosse S, Pearce Drakeley C, Roper C, Khalil IF, Nkya WM, Theander TG, Bygbjerg IC. A simple high throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in DHFR, DHPS and Pfcrt genes using an enzyme linked immunosorbent assay- based technology. Am J Trop Med Hyg. 2005 Feb; (2): 155-62. 9-IF Khalil, M Alifrangis, DS Tarimo, T Staalsø, GMH Satti, TG Theander, AM Rønn, IC. Bygbjerg. Role of the pfcrt 76T, pfmdr-1 86Y mutations, immunity and initial parasite density in predicting the in vivo outcome to chloroquine treatment in two areas with different transmission intensities. Annals of Tropical Medicine and parasitology. 2005; 99:441-448. 10-Alifrangis M, Enosse S, Khalil IF, Tarimo D, Lemnge MM, Thompson R, Bygbjerg IC. Prediction of P. falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in DHFR and DHPS genes: a comparative study between sites of differing endemicity. Am J Trop Med Hyg. 2003 Dec; (69): 601-6
11- Alifrangis M, Lemnge MM, Rønn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC. Increasing prevalence of wild types in DHFR gene of P. falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets. Am J Trop Med Hyg. 2003 Sep; 69 (3): 238-43. 12- KhalilL IF, Rønn AM, Alifrangis M, Abdelgabar H,, Satti GMH and Bygbjerg IC. DHFR and DHPS genotypes associated with in vitro resistance of P. falciparum to pyrimethamine, trimethoprim, sulfadoxine and sulfamethoxazole. Am J Trop Med Hyg. 2003 May; (5): 586-9 13- KhalilL IF, Alifrangis M, Rønn AM, Abdelgabar H, Jelinek T , Satti GMH and Bygbjerg IC. sulfadoxine/pyrimethamine combination in the treatment of uncomplicated falciparum malaria: relation between DHFR/DHPS genotypes, sulfadoxine plasma levels and treatment outcome. Am J Trop Med Hyg. 2002 Sep; 67 (3):225-9.
There are many factors related to breast cancer. This section of the book covers issues such as Red Meat, Western vs. Eastern Diet, Alcohol, Anti-Oxidants, Obesity, and other components that affect our health, such as Information about Trans-Fats, Hydrogenated Oils, Broken Fats that may be harmful, and the Essential Fatty Acids that have beneficial anti-oxidant benefits. There are many fac